Looking ahead into the latter half of the decade, the industry is preparing for a period of sustained high-value growth. The Nanoparticle Analysis Market Projections for 2026 and beyond suggest that the market is on a firm trajectory to exceed $8.45 billion by 2029. This optimistic outlook is anchored by the "Clinical Maturity" of nanomedicine; as dozens of nanoparticle-based drugs move...